2020 Q3 Form 10-Q Financial Statement

#000119312520291255 Filed on November 12, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3
Revenue $6.265M $7.008M
YoY Change -10.6% 9.18%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $169.0K $153.0K
YoY Change 10.46% 2.68%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $1.377M $2.422M
YoY Change -43.15% 23.76%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $1.843M $1.515M
YoY Change 21.65% 18.45%
Income Tax $512.0K $415.0K
% Of Pretax Income 27.78% 27.39%
Net Earnings $1.331M $1.100M
YoY Change 21.0% 17.77%
Net Earnings / Revenue 21.25% 15.7%
Basic Earnings Per Share $0.44 $0.33
Diluted Earnings Per Share $0.44 $0.33
COMMON SHARES
Basic Shares Outstanding 3.031M 3.305M
Diluted Shares Outstanding 3.041M 3.357M

Balance Sheet

Concept 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $15.70M $9.376M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $10.08M $10.64M
YoY Change -5.23% 0.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $700.0K $1.400M
YoY Change -50.0% -65.85%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $726.0M $678.2M
YoY Change 7.05% 3.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.200M $2.000M
YoY Change -40.0% 81.82%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $4.400M $3.100M
YoY Change 41.94% 47.62%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.200M $2.000M
YoY Change -40.0% 81.82%
LONG-TERM LIABILITIES
Long-Term Debt $3.000M $0.00
YoY Change
Other Long-Term Liabilities $8.100M $7.300M
YoY Change 10.96% 30.36%
Total Long-Term Liabilities $11.10M $7.300M
YoY Change 52.05% 30.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.200M $2.000M
Total Long-Term Liabilities $11.10M $7.300M
Total Liabilities $642.5M $600.9M
YoY Change 6.91% 4.62%
SHAREHOLDERS EQUITY
Retained Earnings $32.05M $29.16M
YoY Change 9.94% -25.88%
Common Stock $49.36M $48.96M
YoY Change 0.82% 0.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $83.55M $77.29M
YoY Change
Total Liabilities & Shareholders Equity $726.0M $678.2M
YoY Change 7.05% 3.47%

Cashflow Statement

Concept 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income $1.331M $1.100M
YoY Change 21.0% 17.77%
Depreciation, Depletion And Amortization $169.0K $153.0K
YoY Change 10.46% 2.68%
Cash From Operating Activities $1.198M $1.867M
YoY Change -35.83% 31016.67%
INVESTING ACTIVITIES
Capital Expenditures $57.00K $84.00K
YoY Change -32.14% -82.2%
Acquisitions
YoY Change
Other Investing Activities -$9.380M -$3.870M
YoY Change 142.38% -74.18%
Cash From Investing Activities -$9.432M -$3.949M
YoY Change 138.85% -74.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.783M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -9.537M -48.14M
YoY Change -80.19% -369.96%
NET CHANGE
Cash From Operating Activities 1.198M 1.867M
Cash From Investing Activities -9.432M -3.949M
Cash From Financing Activities -9.537M -48.14M
Net Change In Cash -17.77M -50.22M
YoY Change -64.62% -2213.8%
FREE CASH FLOW
Cash From Operating Activities $1.198M $1.867M
Capital Expenditures $57.00K $84.00K
Free Cash Flow $1.141M $1.783M
YoY Change -36.01% -482.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Cash And Due From Banks
CashAndDueFromBanks
13762000
CY2020Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
31529000
CY2020Q3 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
1934000
CY2020Q2 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
1938000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10081000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10193000
CY2020Q3 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
440000
CY2020Q2 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
386000
CY2020Q3 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
9415000
CY2020Q2 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
9345000
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
707000
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
630000
CY2020Q3 us-gaap Other Assets
OtherAssets
588000
CY2020Q2 us-gaap Other Assets
OtherAssets
634000
CY2020Q3 us-gaap Assets
Assets
726004000
CY2020Q2 us-gaap Assets
Assets
735517000
CY2020Q3 us-gaap Demand Deposit Accounts
DemandDepositAccounts
42169000
CY2020Q2 us-gaap Demand Deposit Accounts
DemandDepositAccounts
87486000
CY2020Q3 iroq Deposits Savings Negotiable Order Of Withdrawal Now And Money Market Deposits
DepositsSavingsNegotiableOrderOfWithdrawalNowAndMoneyMarketDeposits
265837000
CY2020Q2 iroq Deposits Savings Negotiable Order Of Withdrawal Now And Money Market Deposits
DepositsSavingsNegotiableOrderOfWithdrawalNowAndMoneyMarketDeposits
232723000
CY2020Q3 us-gaap Interest Bearing Domestic Deposit Certificates Of Deposits
InterestBearingDomesticDepositCertificatesOfDeposits
281386000
CY2020Q2 us-gaap Interest Bearing Domestic Deposit Certificates Of Deposits
InterestBearingDomesticDepositCertificatesOfDeposits
269152000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
49239000
CY2020Q3 iroq Brokered Certificates Of Deposit
BrokeredCertificatesOfDeposit
12339000
CY2020Q2 iroq Brokered Certificates Of Deposit
BrokeredCertificatesOfDeposit
12339000
CY2020Q3 us-gaap Deposits
Deposits
601731000
CY2020Q2 us-gaap Deposits
Deposits
601700000
CY2020Q3 us-gaap Other Postretirement Defined Benefit Plan Liabilities Current And Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesCurrentAndNoncurrent
3322000
CY2020Q2 us-gaap Other Postretirement Defined Benefit Plan Liabilities Current And Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesCurrentAndNoncurrent
3306000
CY2020Q3 us-gaap Other Liabilities
OtherLiabilities
4794000
CY2020Q2 us-gaap Other Liabilities
OtherLiabilities
5653000
CY2020Q3 us-gaap Liabilities
Liabilities
642457000
CY2020Q2 us-gaap Liabilities
Liabilities
652953000
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
32000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
32000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
49326000
CY2020Q3 us-gaap Unearned Esop Shares
UnearnedESOPShares
2069000
CY2020Q2 us-gaap Unearned Esop Shares
UnearnedESOPShares
2117000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
726004000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
735517000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
32053000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
31207000
CY2020Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
5353000
CY2019Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
5897000
CY2020Q3 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
840000
CY2019Q3 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
919000
CY2020Q3 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
11000
CY2019Q3 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
30000
CY2020Q3 iroq Federal Home Loan Bank Dividends
FederalHomeLoanBankDividends
34000
CY2019Q3 iroq Federal Home Loan Bank Dividends
FederalHomeLoanBankDividends
23000
CY2020Q3 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
27000
CY2019Q3 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
139000
CY2020Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
6265000
CY2019Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
7008000
CY2020Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1235000
CY2019Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
2283000
CY2020Q3 us-gaap Interest Expense
InterestExpense
1377000
CY2019Q3 us-gaap Interest Expense
InterestExpense
2422000
CY2020Q3 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
160000
CY2019Q3 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
162000
CY2020Q3 us-gaap Brokerage Commissions Revenue
BrokerageCommissionsRevenue
225000
CY2019Q3 us-gaap Brokerage Commissions Revenue
BrokerageCommissionsRevenue
235000
CY2020Q3 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
90000
CY2020Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2877000
CY2019Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2665000
CY2020Q3 us-gaap Occupancy Net
OccupancyNet
229000
CY2019Q3 us-gaap Occupancy Net
OccupancyNet
255000
CY2020Q3 us-gaap Equipment Expense
EquipmentExpense
423000
CY2019Q3 us-gaap Equipment Expense
EquipmentExpense
386000
CY2019Q3 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
28000
CY2020Q3 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
33000
CY2019Q3 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
30000
CY2020Q3 us-gaap Advertising Expense
AdvertisingExpense
84000
CY2019Q3 us-gaap Advertising Expense
AdvertisingExpense
121000
CY2020Q3 us-gaap Noninterest Expense
NoninterestExpense
4472000
CY2020Q3 iroq Telephone And Postage
TelephoneAndPostage
50000
CY2020Q3 us-gaap Professional Fees
ProfessionalFees
100000
CY2019Q3 us-gaap Professional Fees
ProfessionalFees
116000
CY2020Q3 iroq Supervisory Examinations
SupervisoryExaminations
35000
CY2019Q3 iroq Supervisory Examinations
SupervisoryExaminations
44000
CY2020Q3 iroq Audit And Accounting Services
AuditAndAccountingServices
73000
CY2019Q3 iroq Audit And Accounting Services
AuditAndAccountingServices
69000
CY2020Q3 iroq Organizational Dues And Subscriptions
OrganizationalDuesAndSubscriptions
22000
CY2019Q3 iroq Organizational Dues And Subscriptions
OrganizationalDuesAndSubscriptions
19000
CY2020Q3 iroq Insurance Bond Premiums
InsuranceBondPremiums
49000
CY2019Q3 iroq Insurance Bond Premiums
InsuranceBondPremiums
41000
CY2019Q3 iroq Telephone And Postage
TelephoneAndPostage
50000
CY2020Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
453000
CY2019Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
367000
CY2019Q3 us-gaap Noninterest Expense
NoninterestExpense
4191000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4888000
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4586000
CY2020Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
4573000
CY2019Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
4640000
CY2019Q3 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
45000
CY2020Q3 us-gaap Gain Loss On Sale Of Loans And Leases
GainLossOnSaleOfLoansAndLeases
563000
CY2019Q3 us-gaap Gain Loss On Sale Of Loans And Leases
GainLossOnSaleOfLoansAndLeases
140000
CY2020Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-9000
CY2019Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-2000
CY2020Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
70000
CY2019Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
70000
CY2020Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
257000
CY2019Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
248000
CY2020Q3 us-gaap Noninterest Income
NoninterestIncome
1742000
CY2019Q3 us-gaap Noninterest Income
NoninterestIncome
1066000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1843000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1515000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
147000
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
868000
CY2020Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
146000
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1000
CY2019Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
867000
CY2020Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-1000
CY2019Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-3000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1333000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1970000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
82564000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2000
CY2020Q3 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
485000
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
31000
CY2020Q3 iroq Esop Shares Earned
EsopSharesEarned
104000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
83547000
CY2019Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
140000
CY2020Q3 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-158000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
82461000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
870000
CY2019Q3 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
521000
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
55000
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
6783000
CY2019Q3 iroq Esop Shares Earned
EsopSharesEarned
105000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
77287000
CY2020Q3 us-gaap Depreciation
Depreciation
169000
CY2019Q3 us-gaap Depreciation
Depreciation
153000
CY2020Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
315000
CY2019Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-54000
CY2019Q3 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-91000
CY2020Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-78000
CY2019Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
342000
CY2020Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
563000
CY2020Q3 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
204000
CY2020Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-9000
CY2019Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-2000
CY2020Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
70000
CY2019Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
70000
CY2020Q3 us-gaap Payments To Purchase Loans Held For Sale
PaymentsToPurchaseLoansHeldForSale
16358000
CY2019Q3 us-gaap Payments To Purchase Loans Held For Sale
PaymentsToPurchaseLoansHeldForSale
5883000
CY2020Q3 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
17457000
CY2019Q3 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
6356000
CY2020Q3 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
104000
CY2019Q3 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
105000
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
31000
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
55000
CY2020Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-293000
CY2019Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
244000
CY2020Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-45000
CY2019Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
296000
CY2020Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-116000
CY2019Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
389000
CY2020Q3 us-gaap Increase Decrease In Postretirement Obligations
IncreaseDecreaseInPostretirementObligations
18000
CY2019Q3 us-gaap Increase Decrease In Postretirement Obligations
IncreaseDecreaseInPostretirementObligations
16000
CY2020Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1343000
CY2019Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-54000
CY2020Q3 iroq Net Increase Decrease In Demand Deposits Money Market Now And Savings Accounts
NetIncreaseDecreaseInDemandDepositsMoneyMarketNowAndSavingsAccounts
-12203000
CY2019Q3 iroq Net Increase Decrease In Demand Deposits Money Market Now And Savings Accounts
NetIncreaseDecreaseInDemandDepositsMoneyMarketNowAndSavingsAccounts
-44353000
CY2020Q3 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
12234000
CY2019Q3 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-6193000
CY2020Q3 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
287000
CY2019Q3 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
100000
CY2020Q3 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
72000000
CY2019Q3 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
8000000
CY2020Q3 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
82500000
CY2019Q3 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
5000000
CY2020Q3 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
645000
CY2020Q3 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
1170000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
1331000
CY2019Q3 us-gaap Profit Loss
ProfitLoss
1100000
CY2020Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1198000
CY2019Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1867000
CY2020Q3 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
13757000
CY2019Q3 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
6596000
CY2020Q3 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
7830000
CY2020Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
7076000
CY2019Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
6034000
CY2020Q3 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
9544000
CY2019Q3 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
3482000
CY2020Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
57000
CY2019Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
84000
CY2020Q3 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
190000
CY2019Q3 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
220000
CY2019Q3 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
41000
CY2020Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9432000
CY2019Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3949000
CY2019Q3 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
1087000
CY2020Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9537000
CY2019Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-48142000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-17771000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-50224000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59600000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9376000
CY2020Q3 us-gaap Interest Paid Net
InterestPaidNet
1493000
CY2019Q3 us-gaap Interest Paid Net
InterestPaidNet
2033000
CY2020Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
610000
CY2019Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
200000
CY2020Q3 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
253000
CY2019Q3 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
28000
CY2020Q3 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
146347
CY2020Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
127102
CY2020Q3 us-gaap Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares
EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares
4811
CY2020Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares
EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares
19245
CY2020Q3 us-gaap Employee Stock Ownership Plan Esop Number Of Suspense Shares
EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares
206884
CY2020Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Suspense Shares
EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares
211695
CY2020Q3 us-gaap Employee Stock Ownership Plan Esop Shares In Esop
EmployeeStockOwnershipPlanESOPSharesInESOP
358042
CY2020Q2 us-gaap Employee Stock Ownership Plan Esop Shares In Esop
EmployeeStockOwnershipPlanESOPSharesInESOP
358042
CY2020Q3 us-gaap Employee Stock Ownership Plan Esop Deferred Shares Fair Value
EmployeeStockOwnershipPlanESOPDeferredSharesFairValue
3200000
CY2020Q2 us-gaap Employee Stock Ownership Plan Esop Deferred Shares Fair Value
EmployeeStockOwnershipPlanESOPDeferredSharesFairValue
3652000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
153143
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.63
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2020Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2020Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2020Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2020Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
153143
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
52155
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.63
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y2M12D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
130857
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
16.63
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y2M12D
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
1331000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
1100000
CY2020Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
3240376
CY2019Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
3533275
CY2020Q3 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
209289
CY2019Q3 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
228534
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3031087
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3304741
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
10101
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3041188
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3356896
CY2020Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
24760000
CY2020Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
117000
CY2020Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
2435000
CY2020Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
13000
CY2020Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
27195000
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
22223000
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
117000
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
2351000
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
106000
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
24574000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
0
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
0
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
6098000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
6654000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
4383000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
4597000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
1997000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
2087000
CY2020Q3 iroq Maximum Amount Of One To Four Family Residential Mortgage Loans Can Be Approved By Loan Officer
MaximumAmountOfOneToFourFamilyResidentialMortgageLoansCanBeApprovedByLoanOfficer
100000
CY2020Q3 iroq Maximum Amount Of Other Secured Loans Residential Mortgage Loans Can Be Approved By Loan Officer
MaximumAmountOfOtherSecuredLoansResidentialMortgageLoansCanBeApprovedByLoanOfficer
50000
CY2020Q3 iroq Maximum Amount Of Unsecured Loans Residential Mortgage Loans Can Be Approved By Loan Officer
MaximumAmountOfUnsecuredLoansResidentialMortgageLoansCanBeApprovedByLoanOfficer
10000
CY2020Q3 iroq Maximum Amount Of One To Four Family Residential Mortgage Loans Can Be Approved By Managing Officer
MaximumAmountOfOneToFourFamilyResidentialMortgageLoansCanBeApprovedByManagingOfficer
375000
CY2020Q3 iroq Maximum Amount Of Other Secured Loans Residential Mortgage Loans Can Be Approved By Managing Officer
MaximumAmountOfOtherSecuredLoansResidentialMortgageLoansCanBeApprovedByManagingOfficer
375000
CY2020Q3 iroq Maximum Amount Of Unsecured Loans Residential Mortgage Loans Can Be Approved By Managing Officer
MaximumAmountOfUnsecuredLoansResidentialMortgageLoansCanBeApprovedByManagingOfficer
100000
CY2020Q3 iroq Maximum Aggregate Loan Amount Of One To Four Family Residential Mortgage Loans Commercial Real Estate Loans Multi Family Real Estate Loans And Land Loans Can Be Approved By Loan Committee
MaximumAggregateLoanAmountOfOneToFourFamilyResidentialMortgageLoansCommercialRealEstateLoansMultiFamilyRealEstateLoansAndLandLoansCanBeApprovedByLoanCommittee
2000000
CY2020Q3 iroq Maximum Amount Of Unsecured Loans Residential Mortgage Loans Can Be Approved By Loan Committee
MaximumAmountOfUnsecuredLoansResidentialMortgageLoansCanBeApprovedByLoanCommittee
500000
CY2020Q3 us-gaap Allowance For Loan And Lease Losses Period Increase Decrease
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecrease
-315000
CY2019Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
6328000
CY2020 us-gaap Allowance For Loan And Lease Losses Period Increase Decrease
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecrease
-128000
CY2020Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
34000
CY2020Q3 us-gaap Line Of Credit
LineOfCredit
3000000
CY2020Q3 iroq Interest Expense Federal Home Loan Bank Federal Reserve Bank Advances And Repurchase Agreements
InterestExpenseFederalHomeLoanBankFederalReserveBankAdvancesAndRepurchaseAgreements
123000
CY2019Q3 iroq Interest Expense Federal Home Loan Bank Federal Reserve Bank Advances And Repurchase Agreements
InterestExpenseFederalHomeLoanBankFederalReserveBankAdvancesAndRepurchaseAgreements
135000
CY2020Q3 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
204000
CY2020Q3 iroq Income Tax Reconciliation Cash Surrender Value Life Insurance
IncomeTaxReconciliationCashSurrenderValueLifeInsurance
14000
CY2020Q3 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
523697000
CY2019Q3 iroq Income Tax Reconciliation Cash Surrender Value Life Insurance
IncomeTaxReconciliationCashSurrenderValueLifeInsurance
14000
CY2020Q3 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
134000
CY2020Q3 us-gaap Aoci Before Tax Attributable To Parent
AociBeforeTaxAttributableToParent
5882000
CY2019Q3 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
1000
CY2020Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
57000
CY2020Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
14000
CY2020Q3 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2020Q3 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
6506000
CY2020Q3 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
1336000
CY2020Q2 us-gaap Aoci Before Tax Attributable To Parent
AociBeforeTaxAttributableToParent
5879000
CY2020Q3 us-gaap Aoci Tax Attributable To Parent
AociTaxAttributableToParent
1677000
CY2020Q2 us-gaap Aoci Tax Attributable To Parent
AociTaxAttributableToParent
1676000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4205000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4203000
CY2020Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
387000
CY2019Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
318000
CY2020Q3 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
2000
CY2019Q3 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
6000
CY2019Q3 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
110000
CY2020Q3 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
7000
CY2019Q3 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
7000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
512000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
415000
CY2020Q3 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
731000
CY2020Q2 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
715000
CY2020Q3 iroq Foreclosed And Repossessed Assets Held For Sale Losses On Assets Fair Value Disclosure
ForeclosedAndRepossessedAssetsHeldForSaleLossesOnAssetsFairValueDisclosure
-30000
CY2019Q3 iroq Foreclosed And Repossessed Assets Held For Sale Losses On Assets Fair Value Disclosure
ForeclosedAndRepossessedAssetsHeldForSaleLossesOnAssetsFairValueDisclosure
0
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15696000
CY2020Q3 iroq Interest Bearing Time Deposits In Banks
InterestBearingTimeDepositsInBanks
3000000
CY2020Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
518241000
CY2020Q3 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
4198000
CY2020Q3 us-gaap Interest Receivable
InterestReceivable
1615000
CY2020Q3 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
4383000
CY2020Q3 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
24000000
CY2020Q3 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
806000
CY2020Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
421000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33467000
CY2020Q2 iroq Interest Bearing Time Deposits In Banks
InterestBearingTimeDepositsInBanks
3000000
CY2020Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
509817000
CY2020Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
3028000
CY2020Q2 us-gaap Interest Receivable
InterestReceivable
1908000
CY2020Q2 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
3738000
CY2020Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
34500000
CY2020Q2 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
519000
CY2020Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
537000
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
268000
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
46000
CY2019Q3 us-gaap Allowance For Loan And Lease Losses Period Increase Decrease
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecrease
54000
CY2019Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
15000
CY2019Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
18000
CY2019Q3 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
6258000
CY2019Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
496903000
CY2019Q3 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
1813000
CY2019Q3 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
495090000
CY2020Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
525033000
CY2020Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
515887000
CY2020Q3 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
94000
CY2019Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
6277000
CY2019Q3 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
19000
CY2020Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
405000
CY2020Q3 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
1298000
CY2020Q2 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
1330000
CY2020Q3 dei Document Type
DocumentType
10-Q
CY2020Q3 dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
CY2020Q3 dei Entity Registrant Name
EntityRegistrantName
IF Bancorp, Inc.
CY2020Q3 dei Security12b Title
Security12bTitle
Common Stock
CY2020Q3 dei Trading Symbol
TradingSymbol
IROQ
CY2020Q3 dei Amendment Flag
AmendmentFlag
false
CY2020Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001514743
CY2020Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2020Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3240376
CY2020Q3 dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2020Q2 us-gaap Line Of Credit
LineOfCredit
3000000
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
6506000
CY2020Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
6234000
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8185000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8016000
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3240376
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3240376
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3240376
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3240376
CY2020Q3 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
44000
CY2019Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
1000
CY2020Q3 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
58000
CY2019Q3 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
345000
CY2020Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
58000
CY2019Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
0
CY2020Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
1000
CY2019Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
2000
CY2020Q3 iroq Esop Shares Earned Shares
ESOPSharesEarnedShares
4811
CY2019Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
304181
CY2019Q3 iroq Stock Repurchased During Period Average Cost Per Share
StockRepurchasedDuringPeriodAverageCostPerShare
22.30
CY2019Q3 iroq Esop Shares Earned Shares
ESOPSharesEarnedShares
4811
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2019Q3 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
1000
CY2019Q3 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
5000000
CY2019Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6783000
CY2020Q3 iroq Debt Securities Greater Than Stated Percentage Of Equity Securities
DebtSecuritiesGreaterThanStatedPercentageOfEquitySecurities
0.10
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
19000
CY2019Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
4000
CY2020Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
162394000
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
12478000
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
13338000
CY2020Q3 iroq Maximum Asset Value Required To Be Maintained Leverage Ratio
MaximumAssetValueRequiredToBeMaintainedLeverageRatio
10000000000
CY2020Q3 us-gaap Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue
73908000
CY2020Q2 us-gaap Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue
66186000
CY2020Q3 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
204000
CY2019Q3 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
1000
CY2020Q3 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2019Q3 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2020Q3 iroq Temporarily Impaired Debt Securities Percentage Of Investment Securities Portfolio
TemporarilyImpairedDebtSecuritiesPercentageOfInvestmentSecuritiesPortfolio
0.17
CY2020Q2 iroq Temporarily Impaired Debt Securities Percentage Of Investment Securities Portfolio
TemporarilyImpairedDebtSecuritiesPercentageOfInvestmentSecuritiesPortfolio
0.16
CY2020Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
154486000
CY2020Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6936000
CY2020Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
130000
CY2020Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
161292000
CY2020Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
155588000
CY2020Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7029000
CY2020Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
223000
CY2020Q1 iroq Tier One Risk Based Capital To Risk Weighted Assets Conservation Buffer
TierOneRiskBasedCapitalToRiskWeightedAssetsConservationBuffer
0.025
CY2020Q3 iroq Unrecognized Financial Instruments
UnrecognizedFinancialInstruments
CY2020Q3 iroq Commitments To Originate Loans
CommitmentsToOriginateLoans
0
CY2020Q2 iroq Commitments To Originate Loans
CommitmentsToOriginateLoans
0
CY2020Q3 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
1336000
CY2020Q3 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
1336000
CY2020Q3 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
1345000
CY2020Q3 iroq Impaired Financing Receivable Interest Income Loss Accrual Method
ImpairedFinancingReceivableInterestIncomeLossAccrualMethod
19000
CY2020Q3 us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
17000
CY2020Q2 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
1660000
CY2020Q2 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
1660000
CY2020 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
1800000
CY2020 iroq Impaired Financing Receivable Interest Income Loss Accrual Method
ImpairedFinancingReceivableInterestIncomeLossAccrualMethod
84000
CY2020 us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
87000
CY2019Q3 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
1813000
CY2019Q3 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
1813000
CY2019Q3 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
19000
CY2019Q3 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
1831000
CY2019Q3 iroq Impaired Financing Receivable Interest Income Loss Accrual Method
ImpairedFinancingReceivableInterestIncomeLossAccrualMethod
15000
CY2019Q3 us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
15000
CY2020Q3 iroq Minimum Period For Default
MinimumPeriodForDefault
P90D
CY2020Q3 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
1588000
CY2020Q3 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
523445000
CY2020Q3 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
142000
CY2020Q2 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
2226000
CY2020Q2 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
513661000
CY2020Q2 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
304000
CY2020Q3 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
0
CY2020Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
485000
CY2019Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
521000
CY2020Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q3 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
286000
CY2020Q2 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
-164000
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
6234000
CY2020Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
1660000
CY2020Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
514227000
CY2020Q3 iroq Mortgage Servicing Rights Fair Value Disclosure
MortgageServicingRightsFairValueDisclosure
731000
CY2020Q3 iroq Fair Value Of Foreclosed Assets
FairValueOfForeclosedAssets
170000
CY2020Q2 iroq Mortgage Servicing Rights Fair Value Disclosure
MortgageServicingRightsFairValueDisclosure
715000
CY2020Q2 iroq Fair Value Of Foreclosed Assets
FairValueOfForeclosedAssets
200000

Files In Submission

Name View Source Status
0001193125-20-291255-index-headers.html Edgar Link pending
0001193125-20-291255-index.html Edgar Link pending
0001193125-20-291255.txt Edgar Link pending
0001193125-20-291255-xbrl.zip Edgar Link pending
d20209d10q.htm Edgar Link pending
d20209dex311.htm Edgar Link pending
d20209dex312.htm Edgar Link pending
d20209dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
iroq-20200930.xml Edgar Link completed
iroq-20200930.xsd Edgar Link pending
iroq-20200930_cal.xml Edgar Link unprocessable
iroq-20200930_def.xml Edgar Link unprocessable
iroq-20200930_lab.xml Edgar Link unprocessable
iroq-20200930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending